September 2026
The global high flow nasal cannula market size was calculated at USD 9.11 billion in 2026 and is projected to hit around USD 21.87 billion by 2035 with a CAGR of 10.29%.
September 2026
The global cannula market size was estimated at USD 204.45 million in 2026 and is projected to surpass around USD 396.60 million by 2034, growing at a CAGR of 7.64%.
September 2026
The global nasal drug delivery technology market size is expected to surge around USD 179.41 billion by 2035 from USD 95.49 billion in 2026, growing at a CAGR of 7.28%.
September 2026
The global intranasal drug delivery devices market size surpassed USD 2,043.63 million in 2026 and is projected to hit around USD 4,949.45 million by 2035, with a noteworthy CAGR of 10.33%.
September 2026
The global nasal mucosa drug supply device market size was evaluated at USD 10.03 billion in 2026 and is predicted to hit around USD 19.71 billion by 2035, growing at a CAGR of 7.80%.
September 2026
The nasal sprays market size reached USD 6.99 billion in 2026, with leading nasal sprays market companies including GlaxoSmithKline plc, Pfizer Inc., Johnson & Johnson, Merck & Co., Inc., Novartis AG.
June 2026
The global nasal polyposis treatment market size is evaluated at USD 5.27 billion in 2025 and is predicted to hit around USD 9.69 billion by 2035, growing at a CAGR of 6.28%.
February 2026
The global nasal aspirate testing market size was evaluated at USD 1.27 billion in 2025 and is predicted to hit around USD 2.10 billion by 2035, growing at a CAGR of 5.13%.
August 2025
The global arterial cannula market size was estimated at USD 33.80 million in 2024 and is projected to surpass around USD 54.12 million by 2034, at a CAGR of 4.82%.
July 2025
The inhalation and nasal spray generic drugs market size is projected to hit around USD 54.44 billion by 2034 from USD 27.38 billion in 2026, with a CAGR of 8.97%.
June 2025
The global nasal irrigation market size is estimated to hit around USD 1,494.40 million by 2034 increasing from USD 374.86 million in 2026, with a CAGR of 18.87%.